Stay updated on FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with site entries in Georgia, New York, Texas, Washington, and Ontario, and updated the page revision to v3.3.3. Removed the older HHS Vulnerability Disclosure link and the prior location sections tied to revision v3.3.2.
    Difference
    0.4%
    Check dated 2025-12-23T20:36:54.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    Added a note that PubMed publications are automatically filled in from PubMed and updated the page revision to v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:13:43.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T18:31:34.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    No significant changes detected on the study details page; the core information and layout remain as previously shown. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T13:05:49.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Updated the page to v3.2.0 with a prominent notice about potential data/tansaction delays due to funding gaps and where to check operating status; previous v3.1.0 reference removed.
    Difference
    3%
    Check dated 2025-10-05T17:39:42.000Z thumbnail image
  9. Check
    106 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0. No substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T11:17:16.000Z thumbnail image

Stay in the know with updates to FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.